We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

123 hedge funds and large institutions have $487M invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

128% more capital invested

Capital invested by funds: $214M → $487M (+$273M)

11% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 38

3% more funds holding

Funds holding: 120 → 123 (+3)

7% more call options, than puts

Call options by funds: $31.7M | Put options by funds: $29.7M

3% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 32

Holders
123
Holders Change
+3
Holders Change %
+2.5%
% of All Funds
3.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
31
Reduced
32
Closed
38
Calls
$31.7M
Puts
$29.7M
Net Calls
+$1.95M
Net Calls Change
+$1.83M

Top Buyers

Rank Fund Capital Flow
1
TAL
TIG Advisors LLC
New York
+$23M
2
CM
Corvex Management
New York
+$15.5M
3
WIC
Water Island Capital
New York
+$14.5M
4
SAM
Sandell Asset Management
New York
+$13.3M
5
Millennium Management
Millennium Management
New York
+$12M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$21.4M
2
O
OrbiMed
New York
-$13.4M
3
State Street
State Street
Massachusetts
-$11.4M
4
PA
Perceptive Advisors
New York
-$10.1M
5
Ameriprise
Ameriprise
Minnesota
-$7.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$1.41M +$78.5K +12,400 +8%
GI
52
GAMCO Investors
Connecticut
$1.34M +$997K +157,573 New
TC
53
TFS Capital
Pennsylvania
$1.28M +$492K +77,696 +106%
GACM
54
Green Arrow Capital Management
New York
$1.25M +$932K +147,259 New
U
55
UBS
Switzerland
$1.19M +$647K +102,318 +269%
TA
56
Teachers Advisors
New York
$1.14M +$35.9K +5,674 +4%
HM
57
Harvest Management
New York
$1.06M +$791K +125,000 New
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$1.05M +$4.19K +662 +0.5%
Nomura Holdings
59
Nomura Holdings
Japan
$1.02M +$776K +122,691 New
PAM
60
Panagora Asset Management
Massachusetts
$1.01M +$452K +71,443 +152%
SM
61
Sabby Management
Florida
$845K +$631K +99,703 New
SG Americas Securities
62
SG Americas Securities
New York
$831K +$620K +97,938 New
ProShare Advisors
63
ProShare Advisors
Maryland
$792K +$96.7K +15,274 +20%
NFA
64
Nationwide Fund Advisors
Ohio
$770K +$53K +8,380 +10%
FNYS
65
First New York Securities
New York
$751K +$560K +88,500 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$706K – – –
BA
67
BlackRock Advisors
Delaware
$701K -$303K -47,950 -37%
MLICM
68
Metropolitan Life Insurance Company (MetLife)
New York
$698K +$11.8K +1,866 +2%
HCM
69
Highbridge Capital Management
New York
$685K -$2.08M -329,158 -80%
PA
70
Pinnacle Associates
New York
$678K +$407K +64,320 +415%
Swiss National Bank
71
Swiss National Bank
Switzerland
$625K -$22.1K -3,500 -5%
Verition Fund Management
72
Verition Fund Management
Connecticut
$608K +$454K +71,732 New
VOYA Investment Management
73
VOYA Investment Management
Georgia
$601K – – –
CCMH
74
Cornerstone Capital Management Holdings
New York
$566K -$929K -146,848 -69%
AIG
75
American International Group
New York
$538K -$4.53K -716 -1%
1 2
3
4 5

ASTX Hedge Fund Activity: Q3 2013 in Review

123 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q3 2013, worth a combined $487M — up 128% from $214M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new ASTX positions and 38 closed out — a net gain of 4 holders — while 31 added to existing stakes and 32 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $23M. The largest seller was Fidelity Investments, cutting an estimated $21.4M.

  • 123 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q3 2013, up from 120 in Q2 2013.
  • Funds reported $487M of ASTEX PHARMACEUTICALS, INC COM stock for Q3 2013, up 128% quarter-over-quarter.
  • 42 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q3 2013 and 38 closed out, a net change of +4 holders.
  • The largest ASTEX PHARMACEUTICALS, INC COM buyer in Q3 2013 was TIG Advisors LLC, an estimated $23M added.
  • The largest ASTEX PHARMACEUTICALS, INC COM seller in Q3 2013 was Fidelity Investments, an estimated $21.4M sold.

Based on aggregated 13F filings for Q3 2013.